Showing results (131-140 of 332) with videos related to
Sort By:
Pageof 34
The Journal of Experimental Medicine|May 1, 1980
Fine specificity of alloimmune cytotoxic T lymphocytes directed against H-2K. A study with Kb mutantsC J Melief, L P de Waal, M Y van der Meulen, et al.Cell|August 10, 1990
Direct binding of peptide to empty MHC class I molecules on intact cells and in vitroT N Schumacher, M T Heemels, J J Neefjes, et al.Cancer Research|August 15, 1996
Protective antitumor immunity induced by immunization with completely allogeneic tumor cellsR E Toes, R J Blom, E van der Voort, et al.Nature|November 7, 1985
Abolition of specific immune response defect by immunization with dendritic cellsC J Boog, W M Kast, H T Timmers, et al.The Journal of Experimental Medicine|March 1, 1996
B lymphocytes secrete antigen-presenting vesiclesG Raposo, H W Nijman, W Stoorvogel, et al.Cancer|October 1, 1978
Surface markers and functional properties of non-Hodgkin's lymphoma cells in relation to histologyA A Bom-Van Noorloos, T A Splinter, P van Heerde, et al.Journal of Virology|October 1, 1986
Tumor progression in murine leukemia virus-induced T-cell lymphomas: monitoring clonal selections with viral and cellular probesH T Cuypers, G C Selten, M Zijlstra, et al.Journal of Molecular Medicine (Berlin, Germany)|October 24, 2000
The role of CD40 in peripheral T cell tolerance and immunityL Diehl, A T Den Boer, E I van der Voort, et al.Transplantation|November 1, 1989
Allograft tolerance induction in adult mice associated with functional deletion of specific CTL precursorsE van Twuyver, W M Kast, R J Mooijaart, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1994
Phase II study of intermittent continuous infusion of low-dose recombinant interleukin-2 in advanced melanoma and renal cell cancerL T Vlasveld, S Horenblas, A Hekman, et al.Pageof 34